SIG | Neuroendocrinology: Neuroendocrine Changes at Menopause in Epilepsy - Molecular and Clinical Insights

Monday, December 7, 2026 at 2:00 PM to 3:30 PM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

This SIG discusses the complex inter-relationships between sex hormones, epilepsy, and anti-seizure medications, with the added complexity of the menopause transition affecting all women with epilepsy. We discuss reciprocal relationships between epilepsy and menopause, including premature ovarian insufficiency and early menopause caused by epilepsy, and how menopause can constitute a second hit for certain comorbidities, such as osteoporosis. We review basic science studies demonstrating impacts of surgical menopause on seizure susceptibility and recommend improved models for pre-clinical research. The SIG then focuses on current and possible future therapeutic options for epilepsy care during the menopause transition.
Learning Objective 1
Understand the complex inter-relationship between sex hormones, epilepsy, anti-seizure medications, and the additive challenges of menopause
Learning Objective 2
Identify impacts of surgical menopause on seizures as shown in pre-clinical models, and describe improved animal models of menopause that could be applied to epilepsy research
Learning Objective 3
State the therapeutic options for care of women with epilepsy during the menopause transition and aging
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesBehavioral Health ProvidersCommunity Health WorkersNursesPharmacistsScientists/ResearchersSocial WorkersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Education Credits
1.5 CME1.5 CNE1.5 CPE
Session ID
NEUROENDOSIG26
Presentation Id
3452244
Event ID
24056
Session Type
Session